Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Emergency Medicine

NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor cardiovascular events,” according to a...

Reuters Health • The Doctor's Channel Daily Newscast

Selective serotonin reuptake inhibitors increase GI bleeding risk

NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI) bleeding, say researchers from Denmark in the...

Reuters Health • The Doctor's Channel Daily Newscast

Triple antiplatelet therapy cuts long-term risk of revascularization

NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to a pooled analysis of data from two randomized trials. ...